THC Inhaler Dosing Schedule for Neuropathic Pain Control
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Existing methods for delivering THC for neuropathic pain relief lack standardization, leading to variable pharmacokinetic profiles and potential adverse effects, hindering its widespread use as a pharmacological treatment.
Innovation Solution
A system and method for controlled pulmonary delivery of THC, limiting the dose to 0.75 mg or less per 2 hours, with a maximum of 10 mg over 24 hours, using an inhaler device with a controller to manage delivery based on a scheduled regimen and decision module, ensuring minimal psychoactive effects.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Reliability
If THC is delivered for neuropathic pain relief, then pain relief efficacy is improved, but psychoactive adverse effects increase
Solution Approach 1:
The patent applies parameter changes by precisely controlling the THC dose parameter to 0.75mg or less per 2-hour period and 10mg or less per 24-hour period. This dosage parameter optimization achieves pain relief while staying below the threshold for significant psychoactive effects, resolving the contradiction between efficacy and adverse effects
Solution Approach 2:
The patent implements periodic action through scheduled dosing intervals of at least 2 hours between administrations. This periodic delivery pattern maintains therapeutic blood concentration levels for pain relief while allowing sufficient time for THC metabolism and elimination, preventing cumulative psychoactive effects
2Stability of the object's composition
If THC delivery is standardized with controlled dosing, then pharmacokinetic profile consistency is improved, but device complexity increases
Solution Approach 1:
The patent applies segmentation by dividing the THC delivery into discrete standardized units (0.75mg per dose) with defined time intervals (2 hours). This segmentation of the delivery process into controlled segments ensures consistent pharmacokinetic profiles while using a relatively simple inhaler device with timer-based control logic
Solution Approach 2:
The patent implements self-service through an automated timer and controller system that automatically tracks dosing times and prevents exceeding dosage limits. The device autonomously manages the complex dosing schedule without requiring user calculation or intervention, simplifying operation while maintaining precise dosing consistency
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
The system provides consistent pharmacokinetic profiles with reduced interindividual variability and minimized adverse effects, effectively reducing neuropathic pain while maintaining a therapeutic window.
Implementation Method 1
an inhaler device for delivering the THC to the subject, the inhaler device comprising a heating mechanism for heating a quantity of THC-comprising material to deliver THC from the quantity of THC-comprising material to the user
Data Source
AI summary
Some embodiments of the invention relate to a system for delivering to a subject at least one pre-determined amount of THC, the system comprising: a memory which stores a scheduled regimen for delivery of THC to the subject, the scheduled regimen defining: a maximal amount of THC to be delivered, the amount being 0.75 mg THC or less, and a time period within which that amount is delivered, the time period being 2 hours or longer; a decision module which decides, according to the scheduled regimen, if a delivery should take place; and an inhaler device for delivering THC to the subject, the inhaler device comprising a controller which carries out delivery of THC based on the decision made by the decision module.